Table 1.
Inclusion and exclusion criteria
| Inclusion criteria | Exclusion criteria |
|---|---|
| 1. 18 < Age < 65 | 1. BMI 35 kg/m2 |
| 2. Kellgren–Laurence grading: II or III | 2. Immune deficiency |
| 3. VAS Index Score | 3. Renal failure (Cr 2 mg/dL) |
| 4. Knee joint alignment 30 degrees | 4. Hepatitis B, C, HIV, HTLV1-2, CMV infections |
| 5. Informed consent | 5. Coagulopathy or using anticoagulant agents |
| 6. Liver malfunction (ALT or AST 100 IU/L) | |
| 7. Uncontrolled diabetes (HbA1c > 8.5%) | |
| 8. Heart diseases (EF < 45%) | |
| 9. Allergy to proteins or cultured substances | |
| 10. Pregnancy or lactation | |
| 11. Malignancy | |
| 12. Addiction | |
| 13. Concurrent corticosteroid therapy | |
| 14. Participating in another clinical trial | |
| 15. Unwillingness to cooperate in the study and follow-ups |
VAS visual analogue scale, BMI body mass index, Cr creatinine, ALT alanine aminotransferase, AST aspartate aminotransferase, HbA1c hemoglobin A1c, EF ejection fraction, CMV cytomegalovirus, HTLV1-2 human T-lymphotropic virus, HIV human immunodeficiency virus